{"path":"Images/Pasted image 20240318091609.png","text":"[ rectalibladdor 7> 355°C | T 3 2. Het > 25%, K*3.8-5 mEq, | 4. Lung re-ventilation | pH>7.3,glycemia 6-9 mm/L | 5. spontaneous or paced HR (> 70 bimin) | | 3.Surgeon = Aortic unclamping | | 6. TEE examination under partial CPB | i + de-airing cardiac cavities | © o checkfor structural defects | + defibrillation | © check for functional defects i step ) <70 bimin Mg ke H *+ Pacing > 100 b/min Mg*, K’ i .Mmpﬂ.. or Conduction block HR Arthythmia_, + Cardioversion | + Isoprenaline 70-100 o amiodarone ¢ - High *'Stop IV fillng |+ Stopwise reductionof g:e“lﬂ:; g “Headuptit | | venous return & pump flow : .+ Diuretics i i 100% - 75% - 50% - 25% -0 oot S MAP >90mmHg . . vasodilators i* Tranfuse autologous blood 70- 90mmHg (NTG, NPS) | (reservoir, cell-saver) L O NED « Trendelenberg position - Successful CPB Weaning * IV colloids, crystalloids | « TEE & Remove arterial canula L OO Syl <70 mmHg Protamine IV & ACT control E Unability to wean from CPB despite preload optimization s i and adequate surgical repair (exclude valve dysfunction, | i coronary graft failure, LV outfiow tract obstruction) ! e L L L L L L L R L LA e Step 2 i TEE i Impaired Appropriate > Lo Ventricular PPIoP asoplegic! Function Syndroms, | 1. INOTROPES = VASOPRESSORS | VASOPRESSORS | |+ Dobutamine or Adrenalinet | VASOPRESSORS | | Norepinephrine | 1. Norepinephrine, | orLevosimedan (or Milrinone) + | | Phenylephrine | Norepinephrine | 2. Terlipressin i | 2. Stepwise reduction of venous return i 3. (Methyleneblue) | | &pumpflow: 100% - 75% -50% -25% - 0 | | 3. Cardiac pacing : bi-ventricular, atrio- = Successful CPB Weaning Lo ventrlouler o] « TEE & Remove arterial canula | 4.Inhaled NO (PG ,) if PH, RV failure i Protamine IV & ACT contro i Unability to wean from CPB despite preload & pharmacological optimization E i (MAP < 70, CI < 2.0 Limin/m?, SVO, < 70%, elevated [lactate’]) ! Step 3 R 2 © Mechanical Circulatory Support","libVersion":"0.3.2","langs":"eng"}